(Q46009424)

18 December 2017

title

What can be achieved with an HIV vaccine? (English)

1 reference

18 December 2017

author name string

J A Levy

series ordinal

1

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

18 December 2017

published in

The Lancet

1 reference

18 December 2017

volume

357

1 reference

18 December 2017

issue

9251

1 reference

18 December 2017

page(s)

223-224

1 reference

18 December 2017

Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Response to experimental challenge in persons immunized with different rubella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Protective immunity against HIV infection: has nature done the experiment for us?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903601-1

7 January 2021

10.1016/S0140-6736(00)03601-1

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017